BIT 0.00% 3.3¢ biotron limited

$10 Billion Deal, page-3427

  1. 16,294 Posts.
    lightbulb Created with Sketch. 746
    Failed to attract a pharma since Sep 2018 who have seen all the detailed data to date so now a group of scientists are going to discuss what to do next.

    What are they going to decide to do when no pharma company doesn't even want to spend another US$6m on another phase 2 trial.

    If BIT thinks it has something raise some more capital and do another Phase 2 trial.


 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.